Literature DB >> 9016796

Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.

Y Yoshida1, H Hamada.   

Abstract

Tetracycline-controllable expression vectors are widely used for inducible expression in mammalian cells. The limitation of this system is the difficulty in expressing high levels of the chimeric transactivator tTA. In this study, we demonstrate a utility of recombinant adenoviruses for the tetracycline-controllable expression system. Unexpectedly, the original tTA transactivator did not show sufficient regulation of the reporter gene expression driven by the tetracycline-responsive promoter (Tet). By adding the nuclear localization signal on the tTA transactivator (NtTA), we achieved tight regulation and high-level induction of the reporter gene expression. The NtTA driven by various promoters demonstrated strict tetracycline controllability at 1 microg/ml of tetracycline and above. The methodology for adenovirus-mediated inducible gene expression has wide applicability. Controllable expression of cytotoxic viral proteins will be applicable for antiviral vaccine productions and pseudotype viral vector generations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016796     DOI: 10.1006/bbrc.1996.5975

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Regulatable systems: applications in gene therapy and replicating viruses.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Site-specific gene integration in cultured silkworm cells mediated by phiC31 integrase.

Authors:  Gaku Nakayama; Yutaka Kawaguchi; Katsumi Koga; Takahiro Kusakabe
Journal:  Mol Genet Genomics       Date:  2005-12-07       Impact factor: 3.291

3.  Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments.

Authors:  M Molin; M C Shoshan; K Ohman-Forslund; S Linder; G Akusjärvi
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 4.  A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

Authors:  Abdelwahed Chtarto; Olivier Bockstael; Terence Tshibangu; Olivier Dewitte; Marc Levivier; Liliane Tenenbaum
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

5.  Adenovirus vector designed for expression of toxic proteins.

Authors:  D Edholm; M Molin; E Bajak; G Akusjärvi
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins.

Authors:  Jun Kitano; Kouji Kimura; Yoshimitsu Yamazaki; Takeshi Soda; Ryuichi Shigemoto; Yoshiaki Nakajima; Shigetada Nakanishi
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

7.  Improved Tet-responsive promoters with minimized background expression.

Authors:  Rainer Loew; Niels Heinz; Mathias Hampf; Hermann Bujard; Manfred Gossen
Journal:  BMC Biotechnol       Date:  2010-11-24       Impact factor: 2.563

8.  Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.

Authors:  Toru Furukawa; Makoto Sunamura; Fuyuhiko Motoi; Seiki Matsuno; Akira Horii
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas.

Authors:  N Shinoura; S Sakurai; F Shibasaki; A Asai; T Kirino; H Hamada
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

10.  Regulated multicistronic expression technology for mammalian metabolic engineering.

Authors:  M Fussenegger; S Moser; J E Bailey
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.